SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Seattle Genetics (SGEN)
An SI Board Since November 2000
Posts SubjectMarks Bans
161 32 0
Emcee:  keokalani'nui Type:  Unmoderated
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
11Added to position today.$Mogul-7/9/2001
10SGEN- added some today.$Mogul-6/29/2001
9David Sorry, I haven't been following this thread until Nigel was kind enouIcebrg-6/5/2001
8BOTHELL, Wash. & SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)-- June 5, 2001nigel bates-6/5/2001
7<What are ya buying these days?> Primarily platforms. HGSI, MLNM, ABGX, IMElmer-3/6/2001
6david, I read that at my age I've last half my syapses. The other 50 % is okeokalani'nui-3/6/2001
5David, I could be totally off, but I think Darwin was sold to a UK company. Thakeokalani'nui-3/6/2001
4Is Seattle Genetics the old Darwin Genetics?Elmer-3/6/2001
3From S-1 Bristol-Myers Squibb We obtained the rights to some of our technologkeokalani'nui-11/25/2000
2J Clin Oncol 2000 Jun;18(11):2282-92 Related Articles, Books, LinkOut Phase Ikeokalani'nui-11/25/2000
1From the S-1: Our lead mAb-drug conjugate, SGN-15, is composed of the mAb BR96 keokalani'nui-11/25/2000
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):